Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 5 open reading frame 24 (C5orf24) encodes a ubiquitously expressed, nuclear-localized protein that is highly conserved across vertebrate species[2][6]. It has alternative transcript variants leading to protein isoforms of 188 and 155 amino acids, containing disordered regions and post-translational modifications such as phosphorylation and ubiquitination[2]. The gene’s function remains largely uncharacterized, but it has been implicated by transcriptomic and genetic association studies as dynamically regulated in response to immune and metabolic stress, especially in the context of post-traumatic stress disorder (PTSD), and is associated with disease traits such as Parkinson's and Crohn's disease[2][4]. Protein interaction studies suggest C5orf24 complexes with key signaling and transcriptional regulators such as STK11 (LKB1), CAB39, PBX1, and others[2][3][5]. There are no known approved drugs or targeted modulators, and its status as a therapeutic target is currently unsubstantiated due to lack of defined function and druggability information[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 5 open reading frame 24 (C5orf24).